• CPI-613: Enhancing Tumor Cell Metabolism Studies and Apoptos

  2026-05-20

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) redefines cancer metabolism research by targeting mitochondrial enzymes crucial for tumor survival. This guide delivers actionable workflows, troubleshooting insights, and applied protocols for leveraging CPI-613 in apoptosis assays and metabolic studies, including acute myeloid leukemia and NSCLC models.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis

  2026-05-19

  The Lipid Peroxidation (MDA) Assay Kit empowers researchers to quantify malondialdehyde with high sensitivity, offering dual colorimetric and fluorescence readouts. This versatile tool drives innovation in oxidative stress and drug resistance studies, supporting robust, reproducible workflows from basic to translational research.

• ECL Western Blotting Substrate: Protocol and Troubleshooting

  2026-05-19

  ECL Western Blotting Substrate (SKU K2187) provides a nonradioactive, luminol-based solution for sensitive horseradish peroxidase detection in Western blot assays. It streamlines protein detection by chemiluminescence, reducing background and allowing for re-probing, but is not suitable for fluorescent or radioisotopic workflows.

• Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular

  2026-05-18

  Metoprolol Tartrate’s high selectivity for β1-adrenergic receptors empowers researchers to dissect cardiac signaling with unprecedented clarity, minimizing off-target effects that confound data. This guide details robust protocols, advanced troubleshooting, and workflow innovations—backed by recent comparative studies—to optimize cardiovascular and hematopoietic experiments.

• Mechanisms of Diuron-Induced Acute Kidney Injury via JAK2/ST

  2026-05-18

  This study integrates network toxicology, transcriptomics, and experimental validation to delineate how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute renal injury. The research identifies the JAK2/STAT1 pathway as a central mediator of Diuron nephrotoxicity, refining risk assessment and guiding future toxicological investigations.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-05-17

  Vacuolin-1 enables precise, reproducible inhibition of Ca2+-dependent lysosomal exocytosis, empowering advanced membrane repair and trafficking research. This article details experimental best practices, troubleshooting strategies, and real-world applications in disease modeling, distinguishing Vacuolin-1 as an essential tool for dissecting lysosomal function.

• Strategic AP-1 Inhibition: SR 11302 for Translational Oncolo

  2026-05-16

  This thought-leadership article explores the mechanistic and translational significance of SR 11302, a selective AP-1 transcription factor inhibitor, for cancer researchers. Integrating mechanistic insight, best-practice protocols, and competitive positioning, the piece highlights how SR 11302 enables precision targeting of tumor-promoting pathways, advances immune modulation strategies, and sets a new standard for chemoprevention and chemotherapy design—moving beyond standard product literature to actionable strategic guidance.

• Dutasteride in Prostate Cancer Research: Mechanisms and Adva

  2026-05-15

  Explore the dual 5-alpha-reductase inhibitor Dutasteride and its advanced applications in prostate cancer and BPH research. This article offers a uniquely technical perspective on apoptosis induction and assay optimization, distinct from standard reviews.

• Methotrexate: Folate Antagonist Mechanisms & Research Protoc

  2026-05-15

  Methotrexate is a well-characterized folate antagonist that inhibits dihydrofolate reductase (DHFR) and modulates DNA synthesis. It is widely employed as an immunosuppressive and anti-inflammatory agent in preclinical research, with robust evidence supporting its use for apoptosis induction in activated T cells and adenosine-mediated anti-inflammatory mechanisms.

• FXR-KLF11 Axis: CDCA Suppresses JAK2/STAT3 in CI-AKI Models

  2026-05-14

  This study reveals that Chenodeoxycholic Acid (CDCA) mitigates contrast-induced acute kidney injury (CI-AKI) by activating FXR, which transcriptionally upregulates KLF11 and suppresses the pro-inflammatory JAK2/STAT3 pathway. The findings clarify a mechanistic pathway for renal protection and inform future research into prophylactic strategies targeting nuclear receptor signaling.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-14

  This study identifies Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) through high-throughput screening of ~6,000 compounds. The results have significant implications for antiviral drug development and highlight the specificity of Merbromin in distinguishing viral proteases from common laboratory proteases such as Proteinase K.

• CD147+ Small Extracellular Vesicles Drive HCC Angiogenesis v

  2026-05-13

  Huang et al. (2023) identify CD147-positive small extracellular vesicles (sEVs) from hepatocellular carcinoma (HCC) cells as a potential diagnostic biomarker and mechanistic driver of angiogenesis. The study demonstrates that these sEVs activate the PI3K/Akt pathway in endothelial cells, promoting angiogenesis and suggesting new avenues for noninvasive diagnosis and targeted intervention.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Researc

  2026-05-13

  ICG001 enables precise dissection of Wnt/β-catenin signaling in fibrosis and cancer models, with robust protocol guidance rooted in recent mechanistic advances. Leverage its selectivity and reproducibility for challenging EMT-driven disease workflows, with actionable troubleshooting to maximize data quality.

• Perospirone Inhibits Kv1.5 Channels: Cardiovascular Insights

  2026-05-12

  This study demonstrates that Perospirone (SM-9018 free base), beyond its established role in serotonergic and dopaminergic modulation for schizophrenia, also exhibits direct, concentration-dependent inhibition of vascular Kv1.5 channels. These findings highlight an off-target action with potential implications for both neuropsychiatric and cardiovascular research models.

• JAK2/STAT1 Pathway in Diuron-Induced Acute Renal Injury: Mec

  2026-05-12

  This study integrates network toxicology, transcriptomics, and in vitro validation to elucidate how Diuron activates the JAK2/STAT1 pathway, leading to acute kidney injury. The findings refine mechanistic understanding of Diuron’s nephrotoxicity and support improved risk assessment in environmental toxicology.

16460 records 1/1098 page Next 12345 下5页 Last page